Trial intelligence / Profile preview

Extension study of levonorgestrel IUS versus etonogestrel implant in women with endometriosis-related pain

RBR-9r8drpPhase 4Not yet recruiting

Sponsor
Faculdade de Ciências Médicas
Start
Feb 2018
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of avatrombopag and etonogestrel in endometriosis (2 arms), sponsored by Faculdade de Ciências Médicas. Planned start Feb 2018; status: not yet recruiting.

02

Drugs

avatrombopagetonogestrel
03

Conditions

endometriosis

Beyond the preview

Go deeper on RBR-9r8drp.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9r8drp.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call